Mohammed A. Khan

发表

The IARC TP53 database: New online mutation analysis and recommendations to users

C. Harris, M. Olivier, R. Eeles, 2002, Human mutation.

Interaction between the microbiome and TP53 in human lung cancer

Eric C. Polley, Paul S. Meltzer, James R. White, 2018, Genome Biology.

Common Genetic Variation in TP53 Is Associated with Lung Cancer Risk and Prognosis in African Americans and Somatic Mutations in Lung Tumors

S. Chanock, E. Bowman, C. Harris, 2007, Cancer Epidemiology Biomarkers & Prevention.

EGFR Somatic Mutations in Lung Tumors: Radon Exposure and Passive Smoking in Former- and Never-Smoking U.S. Women

Leah E. Mechanic, C. Harris, Mohammed A. Khan, 2012, Cancer Epidemiology, Biomarkers & Prevention.

EML4-ALK induces cellular senescence in mortal normal human cells and promotes anchorage-independent growth in immortalized normal human cells

M. Seike, C. Harris, Mohammed A. Khan, 2020 .

Alleile Deletion Analysis of the FHIT Gene Predicts Poor Survival in Non-Small Cell Lung Cancer

L. Liotta, A. Gemma, C. Harris, 2006 .

Alterations of p14 ARF , p53 , and p73 Genes Involved in the E2F-1-mediated Apoptotic Pathways in Non-Small Cell Lung Carcinoma

L. Liotta, J. Herman, J. Jett, 2001 .

Alterations of p 14 ARF , p 53 , and p 73 Genes Involved in the E 2 F-1-mediated Apoptotic Pathways in Non-Small Cell Lung Carcinoma

L. Liotta, J. Herman, J. Jett, 2001 .

EML4-ALK induces cellular senescence in mortal normal human cells and promotes anchorage-independent growth in hTERT-transduced normal human cells

A. Gemma, M. Seike, C. Harris, 2020, BMC Cancer.

Advances in Brief Human Mesothelioma Samples Overexpress Both Cyclooxygenase-2 ( COX-2 ) and Inducible Nitric Oxide Synthase ( NOS 2 ) : In Vitro Antiproliferative Effects of a COX-2 Inhibitor

C. Harris, Mohammed A. Khan, H. Pass, 2000 .

Identification of a functional SNP in the 3'UTR of CXCR2 that is associated with reduced risk of lung cancer.

Jun Yokota, Takashi Kohno, E. Bowman, 2015, Cancer research.

High miR‐21 expression from FFPE tissues is associated with poor survival and response to adjuvant chemotherapy in colon cancer

E. Bowman, Mohammed A. Khan, M. Okajima, 2014, International journal of cancer.

Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease-Associated Colorectal Cancers.

M. Pittman, K. Kinzler, B. Vogelstein, 2016, Gastroenterology.

8-24-2018 Interaction between the microbiome and TP 53 in human lung cancer

Archana S Bhat, Sergey V. Balashov, Julia Oh, 2018 .

The adaptive imbalance in base excision-repair enzymes generates microsatellite instability in chronic inflammation.

Leah E. Mechanic, V. Rotter, C. Harris, 2003, The Journal of clinical investigation.

Differential effects of p53 mutants on the growth of human bronchial epithelial cells

C. Harris, Mohammed A. Khan, J. Pietenpol, 1997, Molecular carcinogenesis.

An analysis of genetic factors related to risk of inflammatory bowel disease and colon cancer.

R. Wolff, J. Potter, C. Croce, 2014, Cancer epidemiology.

MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non-small cell lung carcinoma.

Jane J. Sohn, A. Schetter, G. Giaccone, 2010, Cancer research.

Molecular epidemiology of human cancer risk: gene–environment interactions and p53 mutation spectrum in human lung cancer

W P Bennett, Mohammed A. Khan, P. Shields, 1999, The Journal of pathology.

Polymorphisms in XPD and TP53 and mutation in human lung cancer.

Leah E Mechanic, Leah E. Mechanic, E. Bowman, 2004, Carcinogenesis.

Macrophages, Nitric Oxide and microRNAs Are Associated with DNA Damage Response Pathway and Senescence in Inflammatory Bowel Disease

Jane J. Sohn, A. Schetter, E. Bowman, 2012, PloS one.

Chronic inflammation promotes retinoblastoma protein hyperphosphorylation and E2F1 activation.

C. Harris, Mohammed A. Khan, D. Dixon, 2005, Cancer research.

Effects of Calorie Restriction and Diet-Induced Obesity on Murine Colon Carcinogenesis, Growth and Inflammatory Factors, and MicroRNA Expression

A. Schetter, C. Croce, C. Harris, 2014, PloS one.

Interaction between the microbiome and TP53 in human lung cancer

Archana S Bhat, Sergey V. Balashov, Julia Oh, 2018, Genome Biology.

Microbiome-TP53 Gene Interaction in Human Lung Cancer

Archana S Bhat, Sergey V. Balashov, Julia Oh, 2018, bioRxiv.

Mutational analysis of p73 and p53 in human cancer cell lines

C. Harris, Mohammed A. Khan, K. Hagiwara, 1999, Oncogene.

TP53 Mutation Spectrum in Lung Cancer Is Not Different in Women and Men

E. Bowman, C. Harris, Mohammed A. Khan, 2005, Cancer Epidemiology Biomarkers & Prevention.

Null Results in Brief TP53 Mutation Spectrum in Lung Cancer Is Not Different in Women and Men

E. Bowman, C. Harris, Mohammed A. Khan, 2005 .

GADD45 induction of a G2/M cell cycle checkpoint.

C. Harris, P. O'Connor, A. Fornace, 1999, Proceedings of the National Academy of Sciences of the United States of America.

p53 and K-ras mutations in lung cancers from former and never-smoking women.

C. Harris, Mohammed A. Khan, M. A. Khan, 2001, Cancer research.

Environmental tobacco smoke, genetic susceptibility, and risk of lung cancer in never-smoking women.

E. Bowman, C. Harris, Mohammed A. Khan, 1999, Journal of the National Cancer Institute.

Mutation analysis of the transforming growth factor-β type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-β

Mohammed A. Khan, M. A. Khan, W. Bennett, 1997, Oncogene.

FHIT mutations in human primary gastric cancer.

C. Harris, Mohammed A. Khan, M. A. Khan, 1997, Cancer research.

Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma.

L. Liotta, J. Jett, C. Harris, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Vascular endothelial growth factor and nitric oxide synthase expression in human lung cancer and the relation to p53.

C. Harris, Mohammed A. Khan, S. Ambs, 1998, British Journal of Cancer.

Alterations of p14ARF, p53, and p73 genes involved in the E2F-1-mediated apoptotic pathways in non-small cell lung carcinoma.

L. Liotta, J. Herman, J. Jett, 2001, Cancer research.

Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease-Associated Colorectal Cancers.

M. Pittman, K. Kinzler, B. Vogelstein, 2016, Gastroenterology.

p53 mutation spectrum in relation to GSTM1, CYP1A1 and CYP2E1 in surgically treated patients with non-small cell lung cancer.

L. Liotta, J. Jett, C. Harris, 1998, Pharmacogenetics.